Skip to main content
Top
Published in: Rheumatology International 12/2017

01-12-2017 | Epidemiology of RMD

Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study

Authors: Suparaporn Wangkaew, Narawudt Prasertwitayakij, Arintaya Phrommintikul, Saowanee Puntana, Juntima Euathrongchit

Published in: Rheumatology International | Issue 12/2017

Login to get access

Abstract

Inception cohort study regarding the causes of death and risk factors for mortality in patients with early systemic sclerosis (SSc), especially diffuse SSc (dcSSc) has not been well elucidated. Therefore, the aim of our study was to determine the causes of death, survival rates, and risk factors for mortality in Thai patients with early SSc of whom the majority belonged to the dcSSc subset. We used an inception cohort of early-SSc patients seen between January 2010 and August 2014. All patients were evaluated for clinical and laboratory data at the study entry and then every 6 months. A total of 115 patients (68 female, 91 dcSSc) were enrolled. The mean ± SD age at onset, duration of disease, and duration of follow-up were 52.5 ± 8.5 years, 12.3 ± 9.2 months, and 27.5 ± 16.4 months, respectively. During the follow-up, 11(9.6%) SSc patients died. The mortality rate was 4.17 per 100 person-years (95% CI 2.31, 7.53). The leading cause of SSc-related death was dilated cardiomyopathy (27.2%). Infection was the most common cause of non-SSc-related death (18.2%). Survival rates at 1, 2, 3, and 4 years after the study entry were 93, 91, 88, and 88%, respectively. In the multivariate Cox regression analysis, ESR ≥ 40 mm/h [HR 8.65 (95% CI 1.66,45.17)], hemoglobin < 10 mg/dL [HR 4.57 (95% CI 1.14,18.34)], and mRSS [HR 1.09 (95% CI 1.03,1.15)] were independent risk factors for mortality. Our data suggest that dilated cardiomyopathy was the most common SSc-related cause of death in Thai patients with early SSc, of whom majority was dcSSc subset. Elevated ESR, anemia, and increased mRSS predicted poor outcome.
Literature
2.
go back to reference Nihtyanova SI, Tang EC, Coghlan JG et al (2010) Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 103:109–115CrossRefPubMed Nihtyanova SI, Tang EC, Coghlan JG et al (2010) Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 103:109–115CrossRefPubMed
3.
go back to reference Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis 69:1809–1815CrossRefPubMed Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis 69:1809–1815CrossRefPubMed
4.
go back to reference Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51:1017–1026CrossRef Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51:1017–1026CrossRef
5.
go back to reference Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208–219CrossRefPubMed Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208–219CrossRefPubMed
6.
go back to reference Poormoghim H, Andalib E, Jalali A et al (2016) Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Rheumatol Int 36:925–934CrossRefPubMed Poormoghim H, Andalib E, Jalali A et al (2016) Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Rheumatol Int 36:925–934CrossRefPubMed
7.
go back to reference Hashimoto A, Tejima S, Tono T et al (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38:1931–1939CrossRefPubMed Hashimoto A, Tejima S, Tono T et al (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38:1931–1939CrossRefPubMed
8.
go back to reference Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thail 85:1204–1209 Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thail 85:1204–1209
9.
go back to reference Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:1971–1978CrossRefPubMed Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:1971–1978CrossRefPubMed
10.
go back to reference Simeon-Aznar CP, Fonollosa-Pla V, Tolosa-Vilella C et al (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94:e1728CrossRef Simeon-Aznar CP, Fonollosa-Pla V, Tolosa-Vilella C et al (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94:e1728CrossRef
11.
go back to reference Czirjak L, Kumanovics G, Varju C et al (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63CrossRefPubMed Czirjak L, Kumanovics G, Varju C et al (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63CrossRefPubMed
12.
go back to reference Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:154–167CrossRef Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:154–167CrossRef
13.
go back to reference Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheumatol 37:75–83CrossRef Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheumatol 37:75–83CrossRef
14.
go back to reference Kim J, Park SK, Moon KW et al (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29:297–302CrossRefPubMed Kim J, Park SK, Moon KW et al (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29:297–302CrossRefPubMed
15.
go back to reference Kuo CF, See LC, Yu KH et al (2011) Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 40:373–378CrossRefPubMed Kuo CF, See LC, Yu KH et al (2011) Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 40:373–378CrossRefPubMed
16.
go back to reference Santosa A, Tan CS, Teng GG et al (2016) Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort. Scand J Rheumatol. 45:1–8CrossRef Santosa A, Tan CS, Teng GG et al (2016) Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort. Scand J Rheumatol. 45:1–8CrossRef
17.
18.
go back to reference Masi AT et al (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Masi AT et al (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
19.
go back to reference LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
20.
go back to reference Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed
21.
go back to reference Osiri M, Deesomchok U, Tugwell P (2001) Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire. Rheumatology (Oxford) 40:555–558CrossRef Osiri M, Deesomchok U, Tugwell P (2001) Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire. Rheumatology (Oxford) 40:555–558CrossRef
22.
go back to reference Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263CrossRefPubMed Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263CrossRefPubMed
23.
go back to reference Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133CrossRefPubMed Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133CrossRefPubMed
24.
go back to reference Avouac J, Walker U, Tyndall A et al (2010) Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR scleroderma trial and research group (EUSTAR) database. J Rheumatol 37:1488–1501CrossRefPubMed Avouac J, Walker U, Tyndall A et al (2010) Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR scleroderma trial and research group (EUSTAR) database. J Rheumatol 37:1488–1501CrossRefPubMed
25.
go back to reference Hudson M, Baron M, Tatibouet S, Furst DE, Khanna D (2014) Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International scleroderma renal crisis survey. Semin Arthritis Rheum 43:666–672CrossRefPubMed Hudson M, Baron M, Tatibouet S, Furst DE, Khanna D (2014) Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International scleroderma renal crisis survey. Semin Arthritis Rheum 43:666–672CrossRefPubMed
26.
go back to reference van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed
27.
go back to reference Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N (2013) Mortality in systemic sclerosis—a single centre study from the UK. Clin Rheumatol 32:1533–1539CrossRefPubMed Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N (2013) Mortality in systemic sclerosis—a single centre study from the UK. Clin Rheumatol 32:1533–1539CrossRefPubMed
28.
go back to reference Bryan C, Knight C, Black CM, Silman AJ (1999) Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 42:2660–2665CrossRefPubMed Bryan C, Knight C, Black CM, Silman AJ (1999) Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 42:2660–2665CrossRefPubMed
29.
go back to reference Hao Y, Hudson M, Baron M et al (2017) Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol (Hoboken, NJ) 69:1067–1077CrossRef Hao Y, Hudson M, Baron M et al (2017) Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol (Hoboken, NJ) 69:1067–1077CrossRef
30.
go back to reference Meier FM, Frommer KW, Dinser R et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research group database. Ann Rheum Dis 71:1355–1360CrossRefPubMed Meier FM, Frommer KW, Dinser R et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research group database. Ann Rheum Dis 71:1355–1360CrossRefPubMed
31.
go back to reference Fransen J, Popa-Diaconu D, Hesselstrand R et al (2011) Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 70:1788–1792CrossRefPubMed Fransen J, Popa-Diaconu D, Hesselstrand R et al (2011) Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 70:1788–1792CrossRefPubMed
32.
go back to reference Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403–413CrossRefPubMed Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403–413CrossRefPubMed
Metadata
Title
Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study
Authors
Suparaporn Wangkaew
Narawudt Prasertwitayakij
Arintaya Phrommintikul
Saowanee Puntana
Juntima Euathrongchit
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3846-7

Other articles of this Issue 12/2017

Rheumatology International 12/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.